Johnson and Johnson says it expects to begin clinical trials by September and could have it available for emergency use in early 2021.
The healthcare company and the Biomedical Research Authority in the US is investing 1 billion dollars in research and development.
Its goal is to provide 1 billion vaccines worldwide.
